+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Drug Discovery Services Market by Process (Target Selection, Validation, Lead Optimization), Type (Medicinal Chemistry, DMPK), Drug Type (Biologics, Small Molecules), Therapeutic (Oncology, Neurology), Company (Tier 1, 2, 3) - Global Forecast to 2025

  • ID: 5144971
  • Report
  • September 2020
  • Region: Global
  • 233 Pages
  • Markets and Markets
1 of 6
The Drug Discovery Services Market is Projected to Reach USD 21.4 Billion by 2025 from USD 11.1 Billion in 2020, at a CAGR of 14.0% during the Forecast Period.

FEATURED COMPANIES

  • Chempartner Co., Ltd.
  • Domainex Ltd.
  • Eurofins Scientific SE
  • Evotec SE
  • Frontage Holdings
  • Jubilant Lifesciences
  • MORE

Increasing R&D spending and initiatives for rare disease and orphan drugs research are set to drive the drug discovery services market.

The major factors driving the growth of this market are the growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, increasing demand for outsourcing analytical testing and clinical trial services, initiatives for research on rare diseases and orphan drugs, and focus on drug discovery. However, the high cost of drug discovery and development and stringent regulations governing drug discovery and animal usage in testing may restrict the growth of this market to a certain extent.

By process, the Hit-to-Lead process accounted for the fastest-growing segment of the drug discovery service market.

The Hit-to-Lead identification process is anticipated to be the fastest-growing segment due to the high outsourcing of these services to CROs by the pharmaceutical companies and the emerging advanced technologies for high-throughput screening (HTS) and H2L as well as reductions in development time.

By type, the Medicinal Chemistry segment accounted for the largest share of the drug discovery service market.

Based on type, the drug discovery services market is segmented into medicinal chemistry services, biology services, and drug metabolism and pharmacokinetics (DMPK). The medicinal chemistry services segment is estimated to account for the largest share of the drug discovery services market due to the widespread application of medicinal chemistry in various phases of preclinical drug discovery to deliver robust candidates.

Oncology segment expected to grow at the fastest growth rate during the forecast period.

Based on the therapeutic area, the drug discovery services market is segmented into oncology, cardiovascular diseases, neurology, infectious and immune system diseases, digestive system diseases, and other therapeutic areas. Of all these therapeutic segments, oncology will grow at the fastest CAGR in the drug discovery services market during the forecast period. The high growth of the oncology segment can be attributed to factors such as the increasing number of patients who have cancer, the subsequent increase in the demand for cancer therapies and the growing R&D expenditure by pharmaceutical companies in this therapeutic area.

Asia Pacific: The fastest-growing region in the drug discovery services market.

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, Several global pharmaceutical firms have entered the APAC market to tap the significant growth opportunities in emerging Asian countries and lower their production costs by shifting their manufacturing and drug discovery R&D operations to the region. As a result, the Asia Pacific region has become a major destination for drug discovery and development. A large number of qualified researchers and low-cost operations in APAC countries, such as India and China, are some of the major factors supporting this trend.

North America: The largest share of the drug discovery services market.

North America, which includes the US and Canada, accounted for the largest share of the drug discovery services market. The large share of this region can primarily be attributed to the presence of well-established CROs; rising R&D expenditure by pharmaceutical & biopharmaceutical companies and the availability of latest techniques, instruments, and facilities for drug discovery research are driving the growth of this region.

Breakdown of Primaries

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:

  • By Company - Tier 1 - 40%, Tier 2 - 30%, Tier 3 - 30%
  • By Designation - Executives - 25%, CXOs - 20%, Managers - 55%
  • By Region - North America - 50%, Europe - 20%, APAC - 20%, RoW - 10%

The drug discovery services market is dominated by a few globally established players such as Thermo Fisher Scientific, Inc. (US), Albany Molecular Research, Inc. (US), Charles River Laboratories International, Inc. (US), Evotec SE (Germany), Domainex (UK), GenScript Biotech Corporation (China), Laboratory Corporation of America Holdings (US), WuXi AppTec (China), Pharmaceutical Product Development, LLC (US), Jubilant Biosys Ltd. (India), Eurofins Scientific SE (Luxembourg), Piramal Enterprises Ltd. (India), and Selvita S.A. (Poland).

Research Coverage:

The report segments the drug discovery services market based on region (North America, Asia Pacific, Europe, and RoW), process (target selection, target validation,hit-to-lead identification, lead optimization and candidate validation), type (medicinal chemistry, biology services, Drug Metabolism and Pharmacokinetics (DMPK)), and drug type (small molecules and biologics), Therapeutic Area (Oncology, Neurology, infectious and Immune System Diseases, Digestive System Disease, Cardiovascular Disease and others), Company type (Tier 1, Tier 2, Tier 3 pharmaceutical companies). The report also provides a comprehensive review of market drivers, challenges, and opportunities in the drug discovery services market.

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the ISH market and provides them with information on key market drivers, challenges, and opportunities.

Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Chempartner Co., Ltd.
  • Domainex Ltd.
  • Eurofins Scientific SE
  • Evotec SE
  • Frontage Holdings
  • Jubilant Lifesciences
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
Figure 1 Drug Discovery Services Market Segmentation
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
1.7 Summary of Changes

2 Research Methodology
2.1 Research Data
Figure 2 Research Design
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
Figure 3 Breakdown of Primary Interviews: by Company Type, Designation, and Region
2.2 Market Size Estimation
2.2.1 Market Size Estimation: Bottom-Up Approach
Figure 4 Bottom-Up Approach
2.2.2 Market Size Estimation: Top-Down Approach
Figure 5 Top-Down Approach
2.2.3 Growth Forecast
2.3 Market Breakdown and Data Triangulation
Figure 6 Data Triangulation Methodology
2.4 Assumptions for the Study

3 Executive Summary
Figure 7 Drug Discovery Services Market, by Process, 2020 Vs. 2025 (USD Million)
Figure 8 Drug Discovery Services Market, by Type, 2020 Vs. 2025
Figure 9 Drug Discovery Services Market, by Drug Type, 2020 Vs. 2025 (USD Million)
Figure 10 Drug Discovery Services Market, by Therapeutic Area
Figure 11 Drug Discovery Services Market, by Region

4 Premium Insights
4.1 Drug Discovery Services Market Overview
Figure 12 Increasing R&D Expenditure in the Pharmaceutical & Biotechnology Industry to Drive Market Growth
4.2 North America: Drug Discovery Services Market, by Drug Type & Country (2020)
Figure 13 Small-Molecule Drugs to Account for the Largest Share of the North American Drug Discovery Services Market in 2020
4.3 Drug Discovery Services Market: Geographic Growth Opportunities
Figure 14 China to Register the Highest Growth in the Drug Discovery Services Market during the Forecast Period

5 Market Overview
5.1 Introduction
Table 1 Drug Discovery Process Overview
5.2 Market Dynamics
Figure 15 Drug Discovery Services Market: Drivers, Restraints, and Opportunities
5.2.1 Drivers
5.2.1.1 Growing R&D Expenditure in the Pharmaceutical & Biopharmaceutical Industry
Figure 16 R&D Spending of Pharma Member Companies, 2001–2018 (USD Billion)
5.2.1.2 Increasing Demand for Outsourcing Analytical Testing and Clinical Trial Services
Figure 17 Active Pharmaceutical Pipeline, January 2009–January 2019
5.2.1.3 Initiatives for Research on Rare Diseases and Orphan Drugs
Table 2 Research Projects Funded by the Irdirc
Figure 18 Number of Orphan Indications Approved in the US (2010–2017)
5.2.1.4 Focus on Drug Discovery
Figure 19 Number of Registered Studies (2005–2017)
5.2.2 Restraints
5.2.2.1 High Cost of Drug Discovery and Development
Table 3 Average Cost of Drugs Approved Per Year, 2004–2013
Figure 20 Average Cost to Develop One New Approved Drug - Including the Cost of Failures
5.2.2.2 Stringent Regulations Governing Drug Discovery and Animal Usage
5.2.3 Opportunities
5.2.3.1 Growth in the Biologics Market
5.2.3.2 Patent Expiries
5.2.3.3 Emerging Markets
5.2.4 Trends
5.2.4.1 Growing Adoption of Artificial Intelligence-Based Tools for Drug Discovery
5.3 Impact of Covid-19 on the Drug Discovery Services Market

6 Drug Discovery Services Market, by Process
6.1 Introduction
Table 4 Drug Discovery Services Market, by Process, 2016–2019 (USD Million)
Table 5 Drug Discovery Services Market, by Process, 2020–2025 (USD Million)
6.2 Target Selection
6.2.1 Increasing Demand for Personalized Medicine to Support the Growth of This Market
Table 6 Drug Discovery Services Market for Target Selection, by Region, 2016–2019 (USD Million)
Table 7 Drug Discovery Services Market for Target Selection, by Region, 2020–2025 (USD Million)
6.3 Target Validation
6.3.1 Rising Number of Drug Discovery Research Activities to Support Market Growth
Table 8 Advantages and Disadvantages of Sirna
Table 9 Drug Discovery Services Market for Target Validation, by Region, 2016–2019 (USD Million)
Table 10 Drug Discovery Services Market for Target Validation, by Region, 2020–2025 (USD Million)
6.4 Hit-To-Lead Identification
6.4.1 Hit-To-Lead Identification is the Largest Process Segment in the Market
Table 11 Drug Discovery Services Market for Hit-To-Lead Identification, by Region, 2016–2019 (USD Million)
Table 12 Drug Discovery Services Market for Hit-To-Lead Identification, by Region, 2020–2025 (USD Million)
6.5 Lead Optimization
6.5.1 Lead Optimization Requires State-Of-The-Art Informatics Systems to Facilitate Transparent Presentation and Analysis
Table 13 Drug Discovery Services Market for Lead Optimization, by Region, 2016–2019 (USD Million)
Table 14 Drug Discovery Services Market for Lead Optimization, by Region, 2020–2025 (USD Million)
6.6 Candidate Validation
6.6.1 Candidate Validation Segment to Grow at a High CAGR during the Forecast Period
Table 15 Drug Discovery Services Market for Candidate Validation, by Region, 2016–2019 (USD Million)
Table 16 Drug Discovery Services Market for Candidate Validation, by Region, 2020–2025 (USD Million)

7 Drug Discovery Services Market, by Type
7.1 Introduction
Table 17 Drug Discovery Services Market, by Type, 2016–2019 (USD Million)
Table 18 Drug Discovery Services Market, by Type, 2020–2025 (USD Million)
7.2 Medicinal Chemistry Services
7.2.1 Wide Applications of Medicinal Chemistry in Drug Discovery are a Major Factor Driving Market Growth
Table 19 Medicinal Chemistry Drug Discovery Services Market, by Region, 2016–2019 (USD Million)
Table 20 Medicinal Chemistry Drug Discovery Services Market, by Region, 2020–2025 (USD Million)
7.3 Biology Services
7.3.1 Restrictions on the USage of Animals in Research Activities may Limit Market Growth
Table 21 Biology Drug Discovery Services Market, by Region, 2016–2019 (USD Million)
Table 22 Biology Drug Discovery Services Market, by Region, 2020–2025 (USD Million)
7.4 Drug Metabolism & Pharmacokinetics
7.4.1 DMPK Studies are Employed at the Discovery, Candidate Selection, Investigational New Drug, and New Drug Application Stages
Table 23 DMPK Drug Discovery Services Market, by Region, 2016–2019 (USD Million)
Table 24 DMPK Drug Discovery Services Market, by Region, 2020–2025 (USD Million)

8 Drug Discovery Services Market, by Drug Type
8.1 Introduction
Table 25 Drug Discovery Services Market, by Drug Type, 2016–2019 (USD Million)
Table 26 Drug Discovery Services Market, by Drug Type, 2020–2025 (USD Million)
8.2 Small-Molecule Drugs
8.2.1 Increasing Number of Start-Ups and New Entrants in the Small-Molecule Drugs Segment will Drive the Growth of This Market during the Forecast Period
Table 27 Drug Discovery Services Market for Small-Molecule Drugs, by Region, 2016–2019 (USD Million)
Table 28 Drug Discovery Services Market for Small-Molecule Drugs, by Region, 2020–2025 (USD Million)
8.3 Biologic Drugs
8.3.1 High Set-Up Costs of the Instruments Required for Biologic Drug Manufacturing may Limit Market Growth to a Certain Extent
Table 29 Drug Discovery Services Market for Biologic Drugs, by Region, 2016–2019 (USD Million)
Table 30 Drug Discovery Services Market for Biologic Drugs, by Region, 2020–2025 (USD Million)

9 Drug Discovery Services Market, by Therapeutic Area
9.1 Introduction
Table 31 Global Number of Clinical Trials, by Therapeutic Area (As of October 2019)
Figure 21 R&D Pipeline, by Therapy Group, 2018 & 2019
Table 32 Drug Discovery Services Market, by Therapeutic Area, 2016–2019 (USD Million)
Table 33 Drug Discovery Services Market, by Therapeutic Area, 2020–2025 (USD Million)
9.2 Oncology
9.2.1 High and Growing Number of Research Studies on Cancer Therapeutics to Support Market Growth
Figure 22 Total Number of Clinical Trials for Oncology, by Region (As of December 2019)
Table 34 Drug Discovery Services Market for Oncology, by Region, 2016–2019 (USD Million)
Table 35 Drug Discovery Services Market for Oncology, by Region, 2020–2025 (USD Million)
9.3 Neurology
9.3.1 Increasing Number of Patients Suffering from Neurological Disorders is Driving Market Growth
Table 36 Drug Discovery Services Market for Neurology, by Region, 2016–2019 (USD Million)
Table 37 Drug Discovery Services Market for Neurology, by Region, 2020–2025 (USD Million)
9.4 Infectious and Immune System Diseases
9.4.1 Emergence of New Infectious Diseases to Drive Market Growth
Table 38 Drug Discovery Services Market for Infectious and Immune System Diseases, by Region, 2016–2019 (USD Million)
Table 39 Drug Discovery Services Market for Infectious and Immune System Diseases, by Region, 2020–2025 (USD Million)
9.5 Digestive System Diseases
9.5.1 As There is a Huge Population Seeking Effective Remedies for Digestive Diseases, Pharmaceutical Companies are Investing Significantly in R&D for the Development of Innovative Drugs
Table 40 Drug Discovery Services Market for Digestive System Diseases, by Region, 2016–2019 (USD Million)
Table 41 Drug Discovery Services Market for Digestive System Diseases, by Region, 2020–2025 (USD Million)
9.6 Cardiovascular Diseases
9.6.1 High Global Burden of Cardiovascular Diseases Has Increased the Focus on Developing Effective Drugs
Table 42 Drug Discovery Services Market for Cardiovascular Diseases, by Region, 2016–2019 (USD Million)
Table 43 Drug Discovery Services Market for Cardiovascular Diseases, by Region, 2020–2025 (USD Million)
9.7 Other Therapeutic Areas
Table 44 Drug Discovery Services Market for Other Therapeutic Areas, by Region, 2016–2019 (USD Million)
Table 45 Drug Discovery Services Market for Other Therapeutic Areas, by Region, 2020–2025 (USD Million)

10 Drug Discovery Services Market, by Company Type
10.1 Introduction
Table 46 Drug Discovery Services Market, by Company Type, 2016–2019 (USD Million)
Table 47 Drug Discovery Services Market, by Company Type, 2020–2025 (USD Million)
10.2 Tier 1 Pharmaceutical Companies
Table 48 Drug Discovery Services Market for Tier 1 Pharmaceutical Companies, by Region, 2016–2019 (USD Million)
Table 49 Drug Discovery Services Market for Tier 1 Pharmaceutical Companies, by Region, 2020–2025 (USD Million)
10.3 Tier 2 Pharmaceutical Companies
Table 50 Drug Discovery Services Market for Tier 2 Pharmaceutical Companies, by Region, 2016–2019 (USD Million)
Table 51 Drug Discovery Services Market for Tier 2 Pharmaceutical Companies, by Region, 2020–2025 (USD Million)
10.4 Tier 3 Pharmaceutical Companies
Table 52 Drug Discovery Services Market for Tier 3 Pharmaceutical Companies, by Region, 2016–2019 (USD Million)
Table 53 Drug Discovery Services Market for Tier 3 Pharmaceutical Companies, by Region, 2020–2025 (USD Million)

11 Drug Discovery Services Market, by Region
11.1 Introduction
Table 54 Drug Discovery Services Market, by Region, 2016–2019 (USD Million)
Table 55 Drug Discovery Services Market, by Region, 2020–2025 (USD Million)
11.2 North America
Figure 23 Total Number of Clinical Trials: Global Vs. North America
Figure 24 North America: Drug Discovery Services Market Snapshot
Table 56 North America: Drug Discovery Services Market, by Country, 2016–2019 (USD Million)
Table 57 North America: Drug Discovery Services Market, by Country, 2020–2025 (USD Million)
Table 58 North America: Drug Discovery Services Market, by Process, 2016–2019 (USD Million)
Table 59 North America: Drug Discovery Services Market, by Process, 2020–2025 (USD Million)
Table 60 North America: Drug Discovery Services Market, by Type, 2016–2019 (USD Million)
Table 61 North America: Drug Discovery Services Market, by Type, 2020–2025 (USD Million)
Table 62 North America: Drug Discovery Services Market, by Drug Type, 2016–2019 (USD Million)
Table 63 North America: Drug Discovery Services Market, by Drug Type, 2020–2025 (USD Million)
Table 64 North America: Drug Discovery Services Market, by Therapeutic Area, 2016–2019 (USD Million)
Table 65 North America: Drug Discovery Services Market, by Therapeutic Area, 2020–2025 (USD Million)
Table 66 North America: Drug Discovery Services Market, by Company Type, 2016–2019 (USD Million)
Table 67 North America: Drug Discovery Services Market, by Company Type, 2020–2025 (USD Million)
11.2.1 US
11.2.1.1 Availability of Advanced R&D Infrastructure Has Driven the Growth of the US Market
Figure 25 US: Pipeline Split of Pharmaceutical and Biotechnology Companies, by Phase (January 2019)
Table 68 Number of Clinical Trials Started in the US, by Company, 2017
Table 69 US: Drug Discovery Services Market, by Process, 2016–2019 (USD Million)
Table 70 US: Drug Discovery Services Market, by Process, 2020–2025 (USD Million)
Table 71 US: Drug Discovery Services Market, by Type, 2016–2019 (USD Million)
Table 72 US: Drug Discovery Services Market, by Type, 2020–2025 (USD Million)
Table 73 US: Drug Discovery Services Market, by Drug Type, 2016–2019 (USD Million)
Table 74 US: Drug Discovery Services Market, by Drug Type, 2020–2025 (USD Million)
Table 75 US: Drug Discovery Services Market, by Therapeutic Area, 2016–2019 (USD Million)
Table 76 US: Drug Discovery Services Market, by Therapeutic Area, 2020–2025 (USD Million)
11.2.2 Canada
11.2.2.1 Preference of Pharmaceutical Companies to Conduct Clinical Trials in Canada to Support Market Growth
Table 77 Number of Active Clinical Trials in Canada, by Condition (2019)
Table 78 Number of Active Clinical Trials in Canada, by Company, 2017
Table 79 Canada: Drug Discovery Services Market, by Process, 2016–2019 (USD Million)
Table 80 Canada: Drug Discovery Services Market, by Process, 2020–2025 (USD Million)
Table 81 Canada: Drug Discovery Services Market, by Type, 2016–2019 (USD Million)
Table 82 Canada: Drug Discovery Services Market, by Type, 2020–2025 (USD Million)
Table 83 Canada: Drug Discovery Services Market, by Drug Type, 2016–2019 (USD Million)
Table 84 Canada: Drug Discovery Services Market, by Drug Type, 2020–2025 (USD Million)
Table 85 Canada: Drug Discovery Services Market, by Therapeutic Area, 2016–2019 (USD Million)
Table 86 Canada: Drug Discovery Services Market, by Therapeutic Area, 2020–2025 (USD Million)
11.3 Europe
Table 87 Europe: Drug Discovery Services Market, by Country, 2016–2019 (USD Million)
Table 88 Europe: Drug Discovery Services Market, by Country, 2020–2025 (USD Million)
Table 89 Europe: Drug Discovery Services Market, by Process, 2016–2019 (USD Million)
Table 90 Europe: Drug Discovery Services Market, by Process, 2020–2025 (USD Million)
Table 91 Europe: Drug Discovery Services Market, by Type, 2016–2019 (USD Million)
Table 92 Europe: Drug Discovery Services Market, by Type, 2020–2025 (USD Million)
Table 93 Europe: Drug Discovery Services Market, by Drug Type, 2016–2019 (USD Million)
Table 94 Europe: Drug Discovery Services Market, by Drug Type,2020–2025 (USD Million)
Table 95 Europe: Drug Discovery Services Market, by Therapeutic Area, 2016–2019 (USD Million)
Table 96 Europe: Drug Discovery Services Market, by Therapeutic Area, 2020–2025 (USD Million)
Table 97 Europe: Drug Discovery Services Market, by Company Type, 2016–2019 (USD Million)
Table 98 Europe: Drug Discovery Services Market, by Company Type, 2020–2025 (USD Million)
11.3.1 Germany
11.3.1.1 Government Support and Flexible Labor Laws are Driving the Growth of the German Drug Discovery Services Market
Table 99 Germany: Drug Discovery Services Market, by Process, 2016–2019 (USD Million)
Table 100 Germany: Drug Discovery Services Market, by Process, 2020–2025 (USD Million)
Table 101 Germany: Drug Discovery Services Market, by Type, 2016–2019 (USD Million)
Table 102 Germany: Drug Discovery Services Market, by Type, 2020–2025 (USD Million)
Table 103 Germany: Drug Discovery Services Market, by Drug Type, 2016–2019 (USD Million)
Table 104 Germany: Drug Discovery Services Market, by Drug Type, 2020–2025 (USD Million)
Table 105 Germany: Drug Discovery Services Market, by Therapeutic Area, 2016–2019 (USD Million)
Table 106 Germany: Drug Discovery Services Market, by Therapeutic Area, 2020–2025 (USD Million)
11.3.2 UK
11.3.2.1 Investment by Pharmaceutical Sponsors in the UK for Drug Discovery Services to Support Market Growth
Figure 26 UK: Pharmaceutical R&D Expenditure, 2013–2017
Table 107 UK: Drug Discovery Services Market, by Process, 2016–2019 (USD Million)
Table 108 UK: Drug Discovery Services Market, by Process, 2020–2025 (USD Million)
Table 109 UK: Drug Discovery Services Market, by Type, 2016–2019 (USD Million)
Table 110 UK: Drug Discovery Services Market, by Type, 2020–2025 (USD Million)
Table 111 UK: Drug Discovery Services Market, by Drug Type, 2016–2019 (USD Million)
Table 112 UK: Drug Discovery Services Market, by Drug Type, 2020–2025 (USD Million)
Table 113 UK: Drug Discovery Services Market, by Therapeutic Area, 2016–2019 (USD Million)
Table 114 UK: Drug Discovery Services Market, by Therapeutic Area, 2020–2025 (USD Million)
11.3.3 France
11.3.3.1 High Number of Oncology Clinical Trials in France to Drive Market Growth
Table 115 Number of Clinical Trials Started in France, by Company, 2017
Table 116 France: Drug Discovery Services Market, by Process, 2016–2019 (USD Million)
Table 117 France: Drug Discovery Services Market, by Process, 2020–2025 (USD Million)
Table 118 France: Drug Discovery Services Market, by Type, 2016–2019 (USD Million)
Table 119 France: Drug Discovery Services Market, by Type, 2020–2025 (USD Million)
Table 120 France: Drug Discovery Services Market, by Drug Type, 2016–2019 (USD Million)
Table 121 France: Drug Discovery Services Market, by Drug Type, 2020–2025 (USD Million)
Table 122 France: Drug Discovery Services Market, by Therapeutic Area, 2016–2019 (USD Million)
Table 123 France: Drug Discovery Services Market, by Therapeutic Area, 2020–2025 (USD Million)
11.3.4 Italy
11.3.4.1 High Number of Clinical Trials and the Low Drug Approval Time are the Major Factors Driving Market Growth
Table 124 Number of Clinical Trials Started in Italy, by Company, 2017
Table 125 Italy: Drug Discovery Services Market, by Process, 2016–2019 (USD Million)
Table 126 Italy: Drug Discovery Services Market, by Process, 2020–2025 (USD Million)
Table 127 Italy: Drug Discovery Services Market, by Type, 2016–2019 (USD Million)
Table 128 Italy: Drug Discovery Services Market, by Type, 2020–2025 (USD Million)
Table 129 Italy: Drug Discovery Services Market, by Drug Type, 2016–2019 (USD Million)
Table 130 Italy: Drug Discovery Services Market, by Drug Type, 2020–2025 (USD Million)
Table 131 Italy: Drug Discovery Services Market, by Therapeutic Area, 2016–2019 (USD Million)
Table 132 Italy: Drug Discovery Services Market, by Therapeutic Area, 2020–2025 (USD Million)
11.3.5 Spain
11.3.5.1 Short Study Start-Up Times and Rising R&D Expenditure to Boost the Growth of the Spanish Market
Figure 27 Spain: Pharmaceutical R&D Expenditure, 2011–2017
Table 133 Spain: Drug Discovery Services Market, by Process, 2016–2019 (USD Million)
Table 134 Spain: Drug Discovery Services Market, by Process, 2020–2025 (USD Million)
Table 135 Spain: Drug Discovery Services Market, by Type, 2016–2019 (USD Million)
Table 136 Spain: Drug Discovery Services Market, by Type, 2020–2025 (USD Million)
Table 137 Spain: Drug Discovery Services Market, by Drug Type, 2016–2019 (USD Million)
Table 138 Spain: Drug Discovery Services Market, by Drug Type, 2020–2025 (USD Million)
Table 139 Spain: Drug Discovery Services Market, by Therapeutic Area, 2016–2019 (USD Million)
Table 140 Spain: Drug Discovery Services Market, by Therapeutic Area, 2020–2025 (USD Million)
11.3.6 Rest of Europe
Table 141 RoE: Drug Discovery Services Market, by Process, 2016–2019 (USD Million)
Table 142 RoE: Drug Discovery Services Market, by Process, 2020–2025 (USD Million)
Table 143 RoE: Drug Discovery Services Market, by Type, 2016–2019 (USD Million)
Table 144 RoE: Drug Discovery Services Market, by Type, 2020–2025 (USD Million)
Table 145 RoE: Drug Discovery Services Market, by Drug Type, 2016–2019 (USD Million)
Table 146 RoE: Drug Discovery Services Market, by Drug Type, 2020–2025 (USD Million)
Table 147 RoE: Drug Discovery Services Market, by Therapeutic Area, 2016–2019 (USD Million)
Table 148 RoE: Drug Discovery Services Market, by Therapeutic Area, 2020–2025 (USD Million)
11.4 Asia Pacific
Table 149 Total Number of Clinical Trials in the APAC, by Therapeutic Area, 2017
Figure 28 APAC: Drug Discovery Services Market Snapshot
Table 150 APAC: Drug Discovery Services Market, by Country, 2016–2019 (USD Million)
Table 151 APAC: Drug Discovery Services Market, by Country, 2020–2025 (USD Million)
Table 152 APAC: Drug Discovery Services Market, by Process, 2016–2019 (USD Million)
Table 153 APAC: Drug Discovery Services Market, by Process, 2020–2025 (USD Million)
Table 154 APAC: Drug Discovery Services Market, by Type, 2016–2019 (USD Million)
Table 155 APAC: Drug Discovery Services Market, by Type, 2020–2025 (USD Million)
Table 156 APAC: Drug Discovery Services Market, by Drug Type, 2016–2019 (USD Million)
Table 157 APAC: Drug Discovery Services Market, by Drug Type, 2020–2025 (USD Million)
Table 158 APAC: Drug Discovery Services Market, by Therapeutic Area, 2016–2019 (USD Million)
Table 159 APAC: Drug Discovery Services Market, by Therapeutic Area, 2020–2025 (USD Million)
11.4.1 China
11.4.1.1 Low Cost of Clinical Trials and Large Pharmaceutical R&D Footprint in China to Drive Market Growth
Table 160 China: Drug Discovery Services Market, by Process, 2016–2019 (USD Million)
Table 161 China: Drug Discovery Services Market, by Process, 2020–2025 (USD Million)
Table 162 China: Drug Discovery Services Market, by Type, 2016–2019 (USD Million)
Table 163 China: Drug Discovery Services Market, by Type, 2020–2025 (USD Million)
Table 164 China: Drug Discovery Services Market, by Drug Type, 2016–2019 (USD Million)
Table 165 China: Drug Discovery Services Market, by Drug Type, 2020–2025 (USD Million)
Table 166 China: Drug Discovery Services Market, by Therapeutic Area, 2016–2019 (USD Million)
Table 167 China: Drug Discovery Services Market, by Therapeutic Area, 2020–2025 (USD Million)
11.4.2 India
11.4.2.1 Low-Cost Services and Availability of Skilled Workforce to Support Market Growth in India
Table 168 India: Drug Discovery Services Market, by Process, 2016–2019 (USD Million)
Table 169 India: Drug Discovery Services Market, by Process, 2020–2025 (USD Million)
Table 170 India: Drug Discovery Services Market, by Type, 2016–2019 (USD Million)
Table 171 India: Drug Discovery Services Market, by Type, 2020–2025 (USD Million)
Table 172 India: Drug Discovery Services Market, by Drug Type, 2016–2019 (USD Million)
Table 173 India: Drug Discovery Services Market, by Drug Type, 2020–2025 (USD Million)
Table 174 India: Drug Discovery Services Market, by Therapeutic Area, 2016–2019 (USD Million)
Table 175 India: Drug Discovery Services Market, by Therapeutic Area, 2020–2025 (USD Million)
11.4.3 Japan
11.4.3.1 Government Initiatives for Drug Innovation to Support Market Growth in Japan
Table 176 Japan: Drug Discovery Services Market, by Process, 2016–2019 (USD Million)
Table 177 Japan: Drug Discovery Services Market, by Process, 2020–2025 (USD Million)
Table 178 Japan: Drug Discovery Services Market, by Type, 2016–2019 (USD Million)
Table 179 Japan: Drug Discovery Services Market, by Type, 2020–2025 (USD Million)
Table 180 Japan: Drug Discovery Services Market, by Drug Type, 2016–2019 (USD Million)
Table 181 Japan: Drug Discovery Services Market, by Drug Type, 2020–2025 (USD Million)
Table 182 Japan: Drug Discovery Services Market, by Therapeutic Area, 2016–2019 (USD Million)
Table 183 Japan: Drug Discovery Services Market, by Therapeutic Area, 2020–2025 (USD Million)
11.4.4 Rest of Asia Pacific
Table 184 RoAPAC: Drug Discovery Services Market, by Process, 2016–2019 (USD Million)
Table 185 RoAPAC: Drug Discovery Services Market, by Process, 2020–2025 (USD Million)
Table 186 RoAPAC: Drug Discovery Services Market, by Type, 2016–2019 (USD Million)
Table 187 RoAPAC: Drug Discovery Services Market, by Type, 2020–2025 (USD Million)
Table 188 RoAPAC: Drug Discovery Services Market, by Drug Type, 2016–2019 (USD Million)
Table 189 RoAPAC: Drug Discovery Services Market, by Drug Type, 2020–2025 (USD Million)
Table 190 RoAPAC: Drug Discovery Services Market, by Therapeutic Area, 2016–2019 (USD Million)
Table 191 RoAPAC: Drug Discovery Services Market, by Therapeutic Area, 2020–2025 (USD Million)
11.5 Rest of the World
Table 192 RoW: Drug Discovery Services Market, by Country, 2016–2019 (USD Million)
Table 193 RoW: Drug Discovery Services Market, by Country, 2020–2025 (USD Million)
Table 194 RoW: Drug Discovery Services Market, by Process, 2016–2019 (USD Million)
Table 195 RoW: Drug Discovery Services Market, by Process, 2020–2025 (USD Million)
Table 196 RoW: Drug Discovery Services Market, by Type, 2016–2019 (USD Million)
Table 197 RoW: Drug Discovery Services Market, by Type, 2020–2025 (USD Million)
Table 198 RoW: Drug Discovery Services Market, by Drug Type, 2016–2019 (USD Million)
Table 199 RoW: Drug Discovery Services Market, by Drug Type, 2020–2025 (USD Million)
Table 200 RoW: Drug Discovery Services Market, by Therapeutic Area, 2016–2019 (USD Million)
Table 201 RoW: Drug Discovery Services Market, by Therapeutic Area, 2020–2025 (USD Million)
Table 202 RoW: Drug Discovery Services Market, by Company Type, 2016–2019 (USD Million)
Table 203 RoW: Drug Discovery Services Market, by Company Type, 2020–2025 (USD Million)
11.5.1 Latin America
11.5.1.1 Increasing Investment and R&D to Drive Market Growth in Latin America
Table 204 Latin America : Drug Discovery Services Market, by Process, 2016–2019 (USD Million)
Table 205 Latin America : Drug Discovery Services Market, by Process 2020–2025 (USD Million)
Table 206 Latin America : Drug Discovery Services Market, by Type, 2016–2019 (USD Million)
Table 207 Latin America: Drug Discovery Services Market, by Type, 2020–2025 (USD Million)
Table 208 Latin America: Drug Discovery Services Market, by Drug Type, 2016–2019 (USD Million)
Table 209 RoW: Drug Discovery Services Market, by Drug Type, 2020–2025 (USD Million)
Table 210 Latin America : Drug Discovery Services Market, by Therapeutic Area, 2016–2019 (USD Million)
Table 211 Latin America : Drug Discovery Services Market, by Therapeutic Area, 2020–2025 (USD Million)
11.5.2 Middle East & Africa (Mea)
11.5.2.1 Growing Pharmaceutical Industry to Drive Market Growth in the Middle East and Africa
Table 212 MEA: Drug Discovery Services Market, by Type, 2016–2019 (USD Million)
Table 213 MEA: Drug Discovery Services Market, by Type, 2020–2025 (USD Million)
Table 214 MEA: Drug Discovery Services Market, by Type, 2016–2019 (USD Million)
Table 215 MEA: Drug Discovery Services Market, by Type, 2020–2025 (USD Million)
Table 216 MEA: Drug Discovery Services Market, by Drug Type, 2016–2019 (USD Million)
Table 217 MEA: Drug Discovery Services Market, by Drug Type, 2020–2025 (USD Million)
Table 218 MEA: Drug Discovery Services Market, by Therapeutic Area, 2016–2019 (USD Million)
Table 219 MEA: Drug Discovery Services Market, by Therapeutic Area, 2020–2025 (USD Million)

12 Competitive Landscape
12.1 Overview
12.2 Market Share Analysis
Figure 29 Drug Discovery Services Market Share (2019)
12.3 Competitive Scenario
12.3.1 Partnerships, Agreements, and Collaborations
Table 220 Partnerships, Agreements, and Collaborations (2018–2020)
12.3.2 Service Launches
Table 221 Service Launches (2018–2020)
12.3.3 Mergers & Acquisitions
Table 222 Mergers & Acquisitions (2018–2020)
12.3.4 Expansions
Table 223 Expansions (2018–2019)
12.4 Competitive Evaluation Matrix
12.4.1 Stars
12.4.2 Pervasive
12.4.3 Dynamic Leaders
12.4.4 Emerging Companies
Figure 30 Global Drug Discovery Services Market: Competitive Leadership Mapping (2019)

13 Company Profiles
(Business Overview, Products Offered, Recent Developments, Publisher View)*
13.1 Laboratory Corporation of America Holdings
Figure 31 Labcorp: Company Snapshot (2019)
13.2 Eurofins Scientific SE
Figure 32 Eurofins Scientific SE: Company Snapshot (2019)
13.3 Charles River Laboratories International
Figure 33 Charles River Laboratories International: Company Snapshot (2019)
13.4 Evotec SE
Figure 34 Evotec SE: Company Snapshot (2019)
13.5 Thermo Fisher Scientific
Figure 35 Thermo Fisher Scientific: Company Snapshot (2019)
13.6 Syngene International Limited
Figure 36 Syngene: Company Snapshot (2019)
13.7 Jubilant Lifesciences
Figure 37 Jubilant Lifesciences: Company Snapshot (2018)
13.8 Genscript Biotech Corporation
Figure 38 Genscript Biotech Corporation: Company Snapshot (2019)
13.9 Piramal Enterprises Limited
Figure 39 Piramal Enterprises Limited: Company Snapshot (2019)
13.10 Wuxi Apptec
Figure 40 Wuxi Apptec: Company Snapshot (2019)
13.11 Selvita (Formerly Selvita CRO S.A.)
Figure 41 Selvita: Company Snapshot (2019)
13.12 Frontage Holdings
Figure 42 Frontage Holdings: Company Snapshot (2019)
13.13 Pharmaceutical Product Development, Llc
Figure 43 Pharmaceutical Product Development: Company Snapshot (2019)
13.14 Shanghai Medicilon, Inc.
13.15 Albany Molecular Research, Inc.
13.16 Aurigene Discovery Technologies (A Subsidiary of Dr. Reddy's Laboratories)
13.17 Domainex Ltd.
13.18 Chempartner Co., Ltd.
13.19 TCG Lifesciences Pvt. Limited
13.20 Viva Biotech (Shanghai) Ltd.

*Business Overview, Products Offered, Recent Developments, Publisher View Might Not be Captured in Case of Unlisted Companies

14 Adjacent Related Markets
14.1 Introduction
14.2 Limitations
14.3 Contract Research Organization (CRO) Service Market
14.3.1 Market Definition
14.3.2 Market Overview
14.3.3 Contract Research Organization Services Market, by Region
Table 224 CRO Services Market, by Region, 2017–2025 (USD Million)
14.3.3.1 North America
Table 225 North America: CRO Services Market, by Country, 2018–2025 (USD Million)
14.3.3.2 Europe
Table 226 Europe: CRO Services Market, by Country, 2018–2025 (USD Million)
14.3.3.3 Asia Pacific
Table 227 Asia Pacific: CRO Services Market, by Country, 2018–2025 (USD Million)
14.4 Clinical Trial Management System (CTMS) Market
14.4.1 Market Definition
14.4.2 Market Overview
14.4.3 CTMS Market, by Region
Table 228 CTMS Market, by Region, 2015–2022 (USD Million)
14.4.3.1 North America
Table 229 North America: CTMS Market, by Country, 2015–2022 (USD Million)
14.4.3.2 Europe
Table 230 Europe: CTMS Market, by Country, 2015–2022 (USD Million)
14.4.3.3 Asia Pacific
Table 231 Asia Pacific: CTMS Market, by Country, 2015–2022 (USD Million)
14.5 Drug Discovery Informatics Market
14.5.1 Market Definition
14.5.2 Market Overview
14.5.3 Drug Discovery Informatics Market, by Region
Table 232 Drug Discovery Informatics Market, by Region, 2017–2025 (USD Million)
14.5.3.1 North America
Table 233 North America: Drug Discovery Informatics Market, by Country, 2017–2025 (USD Million)
14.5.3.2 Europe
Table 234 Europe: Drug Discovery Informatics Market, by Country, 2017–2025
14.5.3.3 Asia Pacific
Table 235 APAC: Drug Discovery Informatics Market, by Country, 2017–2025 (USD Million)

15 Appendix
15.1 Discussion Guide
15.2 Knowledge Store: Subscription Portal
15.3 Available Customizations
15.4 Related Reports
15.5 Author Details

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • Albany Molecular Research, Inc.
  • Aurigene Discovery Technologies (A Subsidiary of Dr. Reddy's Laboratories)
  • Charles River Laboratories International
  • Chempartner Co., Ltd.
  • Domainex Ltd.
  • Eurofins Scientific SE
  • Evotec SE
  • Frontage Holdings
  • Genscript Biotech Corporation
  • Jubilant Lifesciences
  • Laboratory Corporation of America Holdings
  • Pharmaceutical Product Development, Llc
  • Piramal Enterprises Limited
  • Selvita (Formerly Selvita CRO S.A.)
  • Shanghai Medicilon, Inc.
  • Syngene International Limited
  • TCG Lifesciences Pvt. Limited
  • Thermo Fisher Scientific
  • Viva Biotech (Shanghai) Ltd.
  • Wuxi Apptec
Note: Product cover images may vary from those shown
6 of 6

Loading
LOADING...

Adroll
adroll